Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What will a PR on the 584 do for us?

I agree that multiple license announcements with big names would be ideal for a new PR. But when you need all the market and investment exposure to kick start the licensing program again, a 584 announcement would be a GOOD first step to that goal.

Share
New Message
Please login to post a reply